International Clinical Trials, Including Trials In Canada, Are Being Stopped Due To Serious Adverse Events With The Drug Zydelig, In Combination With Other Cancer Drugs
Summary Zydelig, a cancer drug, is being removed from clinical trials across Canada and internationally because participants experienced serious adverse events when the drug was combined with other cancer medications. The recall affects patients who are currently enrolled in these clinical trials.
- Category
- consumer product recall
- Country
- Canada
- Agency
- HC-PRODUCTS
- Recall date
- 2016-03-17
- Status
- Closed
- Distribution
- Canada-wide
Official recall notice from HC-PRODUCTS
Recall details on Nibble Recalls: https://trynibble.app/recalls/93de1c08-c91f-4369-9d83-75c1ebdaa468